Immunome, Inc. · NASDAQ:IMNM
Rosett Max received 47,250 Immunome, Inc. shares as an award (Form 4)
Traded Jul 23, 2026 · Filed Jul 27, 2026
On Jul 23, 2026, Rosett Max (Chief Financial Officer) received 47,250 Immunome, Inc. shares as an award, leaving 101,287 shares. Filed Jul 27, 2026 (Form 4).
- Awarded
- 47,250 shares
- Holding after
- 101,287 shares
- Trading plan
- No
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 23, 2026 | Common Stock | Award | 47,250 | 101,287 | Direct |
Source
Related
- Immunome, Inc.
- Rosett Max
- Immunome, Inc. shareholders
- Form 4 · Rosett Max · Jun 17, 2026
- Form 4 · Rosett Max · Apr 3, 2026
- Form 4 · Higgins Jack · Sep 15, 2026
- Schedule 13G/A · Sirenia Capital Management LP · Aug 14, 2026
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · Aug 14, 2026
- Form 4 · Barchas Isaac · Aug 12, 2026
- Form 4 · Barchas Isaac · Aug 10, 2026